These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21285383)

  • 41. The value of molecular expression of KIT and KIT ligand analysed using real-time polymerase chain reaction and immunohistochemistry as a prognostic indicator for canine cutaneous mast cell tumours.
    Costa Casagrande TA; de Oliveira Barros LM; Fukumasu H; Cogliati B; Chaible LM; Dagli ML; Matera JM
    Vet Comp Oncol; 2015 Mar; 13(1):1-10. PubMed ID: 23294979
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VEGF expression in dog mastocytoma.
    Mederle O; Mederle N; Bocan EV; Ceauşu R; Raica M
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):185-8. PubMed ID: 20509299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Canine histiocytic neoplasia: an overview.
    Fulmer AK; Mauldin GE
    Can Vet J; 2007 Oct; 48(10):1041-3, 1046-50. PubMed ID: 17987966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canine epitheliotropic cutaneous T-cell lymphoma: an investigation of T-cell receptor immunophenotype, lesion topography and molecular clonality.
    Moore PF; Affolter VK; Graham PS; Hirt B
    Vet Dermatol; 2009 Oct; 20(5-6):569-76. PubMed ID: 20178496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
    Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
    Meyer A; Gruber AD; Klopfleisch R
    Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Array-based comparative genomic hybridization-guided identification of reference genes for normalization of real-time quantitative polymerase chain reaction assay data for lymphomas, histiocytic sarcomas, and osteosarcomas of dogs.
    Tsai PC; Breen M
    Am J Vet Res; 2012 Sep; 73(9):1335-43. PubMed ID: 22924713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytomorphometry of canine cutaneous histiocytoma.
    Paździor-Czapula K; Otrocka-Domagała I; Rotkiewicz T; Gesek M
    Pol J Vet Sci; 2014; 17(3):413-20. PubMed ID: 25286647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Widespread mismatch repair protein expression in canine cutaneous mast cell tumors.
    Munday JS; French AF; Gibson IR; Gwynne K
    Vet Pathol; 2009 Mar; 46(2):227-32. PubMed ID: 19261633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HSP32 and HSP90 Immunoexpression, in Relation to Kit Pattern, Grading, and Mitotic Count in Canine Cutaneous Mast Cell Tumors.
    Romanucci M; Massimini M; Ciccarelli A; Malatesta D; Bongiovanni L; Gasbarre A; Della Salda L
    Vet Pathol; 2017 Mar; 54(2):222-225. PubMed ID: 27627984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
    Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
    Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical expression of p63 and deltaNp63 in mixed tumors of canine mammary glands and its relation with p53 expression.
    Bertagnolli AC; Cassali GD; Genelhu MC; Costa FA; Oliveira JF; Gonçalves PB
    Vet Pathol; 2009 May; 46(3):407-15. PubMed ID: 19176510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Manfredi MJ; Sorenmo KU
    Vet Pathol; 2005 May; 42(3):350-3. PubMed ID: 15872381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of major histocompatibility complex class II antigen in neoplastic cells of canine cutaneous histiocytoma.
    Kipar A; Baumgärtner W; Kremmer E; Frese K; Weiss E
    Vet Immunol Immunopathol; 1998 Mar; 62(1):1-13. PubMed ID: 9618864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
    Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
    Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
    Myers NC; Andrews GA; Chard-Bergstrom C
    Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytologic identification of erythrophagocytic neoplasms in dogs.
    Barger AM; Skowronski MC; MacNeill AL
    Vet Clin Pathol; 2012 Dec; 41(4):587-9. PubMed ID: 23016693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.